Sign in
CompletedNo phase

Preoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction

Key facts

Who runs it
George Washington University
Where
Washington D.C., United StatesSee the site
Trial code
Status
Completed
People taking part
30 people enrolled
Started
3 Jun 2024
Ended
1 Feb 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Systane iLux Treatment
Record updated
15 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age greater than 18 at the time of informed consent
  • Must understand; be willing and able, and likely to fully comply with study procedures, visit schedule, and restrictions
  • Upcoming scheduled senile cataract surgery

Who cannot take part

  • Patients with active ocular infection, active ocular inflammation or history of chronic, recurrent ocular inflammation within prior 3 months
  • Ocular surgery within the last 6 months
  • Occlusion therapy with lacrimal or punctum plugs within the last 3 months
  • Patients with ocular injury or trauma, chemical burns, or limbal stem cell deficiency (within prior 3 months)
  • Previous application/administration of Systane iLux or LipiFlow treatment
  • Patients with cicatricial lid margin disease
  • Eyelid abnormalities
  • Patients with an ocular surface abnormality that may compromise corneal integrity
  • patients with lid surface abnormalities that affect lid function in either eye; patients with aphakia
  • Patients with permanent makeup or tattoos on their eyelids

Where in United States

  • George Washington UniversityWashington D.C., United States

About the trial

What the trial wants to find out

This prospective study will investigate the effect of pre-operative Systane iLux system administration in treated cataract induced dry eye disease.

The 2 groups in the trial

  • Control: No Systane iLux TreatmentNo study treatment, for comparison

    No Systane iLux treatment at baseline visit two weeks prior to cataract surgery.

  • Systane iLux TreatmentTreatment being tested

    Systane iLux administration at baseline visit two weeks prior to cataract surgery.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Efficacy of the Systane iLux System on Preoperative Cataract Patients on Dry Eye Disease Due to Meibomian Gland Dysfunction
Record updated
15 May 2026